Brillio partnered with a global biopharmaceutical leader to modernize its commercial operations and unlock new levels of agility, efficiency, and patient impact. Confronted with fragmented data, manual reporting, and limited dashboard interactivity, the client needed a transformative solution that could unify insights, accelerate decision-making, and improve patient engagement.
Through an AI- and GenAI-powered transformation, Brillio integrated IQVIA, CRM, claims, and sales data into a unified 360-degree patient view, automated SQL reporting with LLM-powered chatbots, and enabled dynamic business guidance through conversational analytics. By embedding AI-driven automation across financial decision-making, contract data retrieval, and coaching feedback analysis, Brillio reduced manual effort by 80%, cut decision cycles by 66%, and delivered up to 85% faster time-to-insight.
Explore the full case study to see how the client achieved 56% cost savings, a 25% increase in field productivity, an 18% improvement in therapy adherence, and faster access to care through reduced reimbursement delays.
